期刊文献+

胰岛素泵强化治疗(短期)影响新诊断2型糖尿病患者胰岛素分泌、敏感性情况观察 被引量:4

原文传递
导出
摘要 目的探究在新诊断2型糖尿病治疗时,使用胰岛素泵强化治疗(短期)对于患者胰岛素分泌、敏感性的影响。方法针对40例新诊断2型糖尿病患者进行治疗,治疗方法均为胰岛素泵强化治疗(短期),并在治疗前后对患者的胰岛素分泌、敏感性情况进行检测,然后比较并统计患者情况。结果患者胰岛素最大分泌量经过治疗出现明显提升,同时患者的HOMA-IR即胰岛素敏感性显著改善,组间比较均为P<0.05则说明差异明显。结论胰岛素泵强化治疗(短期)影响新诊断2型糖尿病患者发现,其能够增加患者的胰岛素分泌,改善患者身体情况,因此值得临床借鉴。
作者 徐俊涛 苏晓
出处 《首都食品与医药》 2018年第13期51-51,共1页 Capital Food Medicine
  • 相关文献

参考文献2

二级参考文献16

  • 1Kharitonenkov A,Shiyanova TL.FGF-21 as a novel metabolic regulator[J].J Clin Invest,2005;115(6):1627-35.
  • 2Cuevas-Ramos D,Almeda-Valdes P,Aguilar-Salinas CA,et al.The role of fibroblast growth factor 21 (FGF21) on energy balance,glucose and lipid metabolism[J].Curr Diabetes Rev,2009;5(4):216-20.
  • 3Matuszek B,Lenart-Lipińska M,Duma D.Evaluation of concentrations of FGF-21--a new adipocytokine in type 2 diabetes[J].Endokrynol Pol,2010;61(1):50-4.
  • 4Chen WW,Li L,Yang GY,et al.Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus[J].Exp Clin Endocrinol Diabetes,2008;116(1):65-8.
  • 5Zhang X,Yeung DC,Karpisek M,et al.Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans[J].Diabetes,2008;57(5):1246-53.
  • 6Stein S,Stepan H,Kratzsch J,et al.Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia[J].Metabolism,2010;59(1):33-7.
  • 7Berglund ED,Li CY,Bina HA,et al.Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity[J].Endocrinology,2009;150(9):4084-93.
  • 8Chavez AO,Molina-Carrion M,Abdul-Ghani MA,et al.Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance[J].Diabetes Care,2009;32(8):1542-6.
  • 9Hojman P,Pedersen M,Nielsen AR,et al.Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia[J].Diabetes,2009;58(12):2797-801.
  • 10Kharitonenkov A,Shanafelt AB.Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases[J].Biol Drugs,2008;22(1):37-44.

共引文献26

同被引文献22

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部